Όλο το DSpace

Πλοήγηση ανά Θέμα "brain size"

Αποτελέσματα 1-9 από 9

    • Anti-cd20 agents for multiple sclerosis: Spotlight on ocrelizumab and ofatumumab 

      Florou D., Katsara M., Feehan J., Dardiotis E., Apostolopoulos V. (2020)
      Until recently, in the pathogenesis of Multiple Sclerosis (MS), the contribution of B cells has been largely underestimated, and the disease was considered a T-cell-mediated disorder. However, newer evidence shows that B ...

    • Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration 

      Rivard L., Friberg L., Conen D., Healey J.S., Berge T., Boriani G., Brandes A., Calkins H., Camm A.J., Yee Chen L., Lluis Clua Espuny J., Collins R., Connolly S., Dagres N., Elkind M.S.V., Engdahl J., Field T.S., Gersh B.J., Glotzer T.V., Hankey G.J., Harbison J.A., Georg Haeusler K., Hills M.T., Johnson L.S.B., Joung B., Khairy P., Kirchhof P., Krieger D., Lip G.Y.H., Løchen M.-L., Madhavan M., Mairesse G.H., Montaner J., Ntaios G., Quinn T.J., Rienstra M., Rosenqvist M., Sandhu R.K., Smyth B., Schnabel R.B., Stavrakis S., Themistoclakis S., Van Gelder I.C., Wang J.-G., Freedman B. (2022)
      Growing evidence suggests a consistent association between atrial fibrillation (AF) and cognitive impairment and dementia that is independent of clinical stroke. This report from the AF-SCREEN International Collaboration ...

    • Brain volume dynamics in multiple sclerosis. A case-control study 

      Andravizou A., Artemiadis A., Bakirtzis C., Siokas V., Aloizou A.-M., Peristeri E., Kapsalaki E., Tsimourtou V., Hadjigeorgiou G.M., Dardiotis E. (2019)
      Objectives: In this study, we aimed to explore the extent and clinical relevance of brain volume dynamics in relapsing remitting multiple sclerosis (RRMS). Methods: Sixty-three patients with RRMS with a disease duration ...

    • Clinically reliable cognitive decline in relapsing remitting multiple sclerosis: Is it the tip of the iceberg? 

      Andravizou A., Siokas V., Artemiadis A., Bakirtzis C., Aloizou A.-M., Grigoriadis N., Kosmidis M.H., Nasios G., Messinis L., Hadjigeorgiou G., Dardiotis E., Peristeri E. (2020)
      Objectives: Cognitive impairment is common in multiple sclerosis, but the brain MRI correlates in relapsing remitting multiple sclerosis remain controversial. The current study aimed to investigate whether cognitive decline ...

    • Cognitive Fatigability is Independent of Subjective Cognitive Fatigue and Mood in Multiple Sclerosis 

      Bakirtzis C., Nikolaidis I., Boziki M.-K., Artemiadis A., Andravizou A., Messinis L., Ioannidis P., Grigoriadis N. (2020)
      Background:Sustained cognitive testing is used to detect cognitive fatigability and is often considered a substitute for subjective cognitive fatigue (CF). However, the relationship between cognitive fatigability and ...

    • The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: A systematic review and meta-analysis 

      Tsivgoulis G., Katsanos A.H., Grigoriadis N., Voumvourakis K., Hadjigeorgiou G.M., Heliopoulos I., Dardiotis E., Papathanasopoulos P., Kilidireas C. (2015)
      Brain atrophy is associated with cognitive deficits in patients with clinically isolated syndrome (CIS) and can predict conversion to clinical definite multiple sclerosis. The aim of the present meta-analysis was to evaluate ...

    • A meta-analysis on potential modifiers of LITT efficacy for mesial temporal lobe epilepsy: Seizure-freedom seems to fade with time 

      Brotis A.G., Giannis T., Paschalis T., Kapsalaki E., Dardiotis E., Fountas K.N. (2021)
      Background: The efficacy of laser interstitial thermal therapy (LITT) in mesial temporal lobe epilepsy (MTLE) has not been clearly established yet. Objective: We conducted a meta-analysis to estimate the efficacy of LITT ...

    • Repetitive Transcranial Magnetic Stimulation, Cognition, and Multiple Sclerosis: An Overview 

      Nasios G., Messinis L., Dardiotis E., Papathanasopoulos P. (2018)
      Multiple sclerosis (MS) affects cognition in the majority of patients. A major aspect of the disease is brain volume loss (BVL), present in all phases and types (relapsing and progressive) of the disease and linked to both ...

    • Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes 

      Paciaroni M., Agnelli G., Giustozzi M., Tsivgoulis G., Yaghi S., Grory B.M., Furie K.L., Tadi P., Zedde M., Abdul-Rahim A.H., Dawson J., Lees K.R., Alberti A., Venti M., Acciarresi M., D’Amore C., Mosconi M.G., Bogini V., Cappellari M., Rigatelli A., Bonetti B., Putaala J., Tomppo L., Tatlisumak T., Bandini F., Marcheselli S., Pezzini A., Poli L., Padovani A., Masotti L., Grifoni E., Vannucchi V., Sohn S.-I., Lorenzini G., Tassi R., Guideri F., Acampa M., Martini G., Ntaios G., Athanasakis G., Makaritsis K., Karagkiozi E., Vadikolias K., Liantinioti C., Palaiodimou L., Mumoli N., Porta C., Galati F., Sacco S., Tiseo C., Corea F., Ageno W., Bellesini M., Silvestrelli G., Ciccone A., Scoditti U., Denti L., Mancuso M., Caselli M.C., Maccarrone M., Ulivi L., Orlandi G., Giannini N., Tassinari T., Lodovici M.L.D., Rueckert C., Baldi A., Toni D., Gentile L., Letteri F., Giuntini M., Lotti E.M., Flomin Y., Pieroni A., Kargiotis O., Karapanayiotides T., Monaco S., Mannino M., Baronello M.M., Csiba L., Szabó L., Chiti A., Giorli E., Sette M.D., Schirinzi E., Imberti D., Zabzuni D., Doronin B., Volodina V., Michel P., Eskandari A., Vanacker P., Barlinn K., Barlinn J., Deleu D., Gourbali V., Caso V. (2020)
      Introduction: The aim of this study in patients with acute posterior ischaemic stroke (PS) and atrial fibrillation (AF) was to evaluate (1) the risks of recurrent ischaemic event and severe bleeding and (2) these risks in ...